Currently, approved treatments for severe ROP are cryotherapy or laser photocoagulation of the avascular regions of retina, but the use of pharmacologic interventions, such as anti-VEGF therapies, have significantly increased [7]. This evidence concerns the gene VEGFA and retinopathy of prematurity.